Luisa Salter-Cid
Corporate Officer/Principal bei Flagship Pioneering
Profil
Luisa Salter-Cid is currently the Chief Scientific Officer & Pioneering Medicines at Flagship Pioneering.
Prior to this, she was the Director at Jounce Therapeutics, Inc. from 2021 to 2023, the Chief Scientific Officer at Gossamer Bio, Inc. from 2018 to 2021, and the Vice President & Head-Immunology at Bristol Myers Squibb Co. from 2005 to 2018.
Dr. Salter-Cid has a graduate degree from Florida International University, an undergraduate degree from the University of Lisbon, and a doctorate from The University of Miami Leonard M.
Miller School of Medicine.
Aktive Positionen von Luisa Salter-Cid
| Unternehmen | Position | Beginn |
|---|---|---|
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Corporate Officer/Principal | 01.01.2021 |
Ehemalige bekannte Positionen von Luisa Salter-Cid
| Unternehmen | Position | Ende |
|---|---|---|
| JOUNCE THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 03.05.2023 |
| GOSSAMER BIO, INC. | Technik-/Wissenschafts-/F&E-Leiter | 30.04.2021 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01.08.2018 |
Ausbildung von Luisa Salter-Cid
| University of Lisbon | Undergraduate Degree |
| The University of Miami Leonard M. Miller School of Medicine | Doctorate Degree |
| Florida International University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| GOSSAMER BIO, INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Jounce Therapeutics, Inc.
 Jounce Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Jounce Therapeutics, Inc. is a clinical stage immunotherapy company, which engages in developing treatments for cancer. It also provides novel cancer immunotherapies to attack tumors. The company was founded by Louis M. Weiner, Drew M. Pardoll, Thomas F. Gajewski, James P. Allison, Robert Schreiber, and Padmanee Sharma in 2013 and is headquartered in Cambridge, MA. | Commercial Services |
Flagship Pioneering
Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Finance |
